DSM-Firmenich AG

“DSM-Firmenich is a genuine specialty ingredients franchise — with durable moats in Fragrance & Taste and Human Nutrition — being valued at IFF-like distressed multiples due to post-merger execution concerns and Animal Nutrition drag. The impending ANH divestiture removes the most structurally impaired segment, and synergy delivery has been creditable, but €4.5–5bn in net debt, dual-CEO governance complexity, and a management team that has not fully rebuilt execution credibility post-merger prevent full conviction. At ~11x clean EV/EBITDA versus 18–22x for Givaudan and Symrise, the valuation gap is real and the permanent capital loss risk is low given asset quality, making this a TRACK for a half-position initiation with conviction to add as ANH closes and deleveraging is demonstrated.”